Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.00    -3.60 (-1.78%)
Bid:
198.80
Ask:
199.20
Spread: 0.40 (0.201%)
Market Cap: £1.29b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Directorate Change

22 Jul 2022 11:33

RNS Number : 4750T
Ashmore Group PLC
22 July 2022
 

 

Ashmore Group plc

22 July 2022

 

DIRECTORATE CHANGE

 

Ashmore Group plc ("Ashmore" / the "Company") today announces the appointment of Shirley Garrood as a Non-executive Director.

 

Shirley Garrood will join the Board as a Non-executive Director with effect from 1 August 2022. Shirley will succeed Clive Adamson as Chair of the Audit and Risk Committee from 14 October 2022, subject to approval from the Financial Conduct Authority, at which point Clive will step down as the Committee's Interim Chair and as a member. Clive will remain Chair of the Company and of its Nominations Committee.

Shirley has extensive executive and relevant non-executive experience in financial services and is a chartered accountant. The Board considers that Shirley will be independent on appointment.

The structure of the Board Committees with effect from 1 August 2022 until 14 October 2022 will be as follows:

 

Audit and Risk

Remuneration

Nominations

Clive Adamson (Interim Chair)

Helen Beck (Chair)

Clive Adamson (Chair)

Helen Beck

Clive Adamson

Helen Beck

Jennifer Bingham

Jennifer Bingham

Jennifer Bingham

Shirley Garrood

Shirley Garrood

Shirley Garrood

 

Shirley was a Non-executive Director of esure Group plc from July 2013 to November 2019, and also a Non-executive Director of Hargreaves Lansdown plc from October 2013 to December 2020 and held various roles including Senior Independent Director and Chair of Audit and Risk committees. There are no other details required to be disclosed pursuant to Listing Rule 9.6.13, in connection with her appointment.

 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plc

Paul Measday

Investor Relations +44 (0)20 3077 6278

 

FTI Consulting

Neil Doyle +44 (0)7771 978 220

Kit Dunford +44 (0)7717 417 038

 

 

 

Notes:

 

 

 

 

Shirley Garrood (Non-executive Director)

Shirley is currently a Non-executive Director of Royal London Mutual Insurance Society Limited, and Chair of Royal London Asset Management Holdings Limited and Royal London Asset Management Limited, chairing their Risk and Capital Committee. She is a Non-executive Director and Chair of the Audit and Risk Committee of the BBC. Shirley is also an Independent Non-Executive Director on Deloitte LLP's Audit Governance Board providing oversight of the external audit and assurance business only.

Shirley's financial services experience includes being Chief Financial Officer and Chief Operating Officer of Henderson Group plc; Chair of the Audit Committee, Senior Independent Director and Deputy Chair of esure Group plc; and Chair of the Audit Committee, Chair of the Risk Committee and Senior Independent Director of Hargreaves Lansdown plc. She also served as a governor of the Peabody Trust housing association.

Shirley holds a B.Sc in Economics and Accounting from the University of Bristol and is a qualified Chartered Accountant and Corporate Treasurer.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLLFLLDLXBBF
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.